Arash Nabbi

778 total citations
20 papers, 434 citations indexed

About

Arash Nabbi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Arash Nabbi has authored 20 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Arash Nabbi's work include Epigenetics and DNA Methylation (9 papers), Cancer-related gene regulation (7 papers) and Genomics and Chromatin Dynamics (5 papers). Arash Nabbi is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), Cancer-related gene regulation (7 papers) and Genomics and Chromatin Dynamics (5 papers). Arash Nabbi collaborates with scholars based in Canada, United Kingdom and France. Arash Nabbi's co-authors include Karl Riabowol, Urszula L. McClurg, Craig Robson, Stuart McCracken, Dieter Fink, Subhash Thalappilly, Tarek A. Bismar, Thomas G. P. Grünewald, Michelle Haber and Trevor J. Pugh and has published in prestigious journals such as Nature reviews. Cancer, Oncogene and Biochemical Journal.

In The Last Decade

Arash Nabbi

19 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arash Nabbi Canada	13	322	91	67	50	45	20	434
Alysia R. Bryll United States	6	378 1.2×	105 1.2×	70 1.0×	33 0.7×	22 0.5×	6	527
Cláudia Miranda Italy	11	223 0.7×	143 1.6×	52 0.8×	72 1.4×	35 0.8×	15	411
Cristina Zahonero Spain	6	174 0.5×	66 0.7×	55 0.8×	36 0.7×	37 0.8×	7	318
Raj Nayan Sewduth Belgium	12	282 0.9×	63 0.7×	51 0.8×	33 0.7×	39 0.9×	22	419
Anders P. Mutvei Sweden	11	362 1.1×	106 1.2×	116 1.7×	32 0.6×	26 0.6×	13	509
Kim Moran‐Jones Australia	13	465 1.4×	63 0.7×	92 1.4×	19 0.4×	30 0.7×	16	562
Alessio Valletti Italy	10	339 1.1×	132 1.5×	75 1.1×	29 0.6×	17 0.4×	15	472
Leire Mendizabal Spain	5	467 1.5×	105 1.2×	86 1.3×	36 0.7×	53 1.2×	7	575
Sara Nicolai Italy	9	310 1.0×	147 1.6×	154 2.3×	27 0.5×	32 0.7×	13	430

Countries citing papers authored by Arash Nabbi

Since Specialization

Citations

This map shows the geographic impact of Arash Nabbi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arash Nabbi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arash Nabbi more than expected).

Fields of papers citing papers by Arash Nabbi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arash Nabbi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arash Nabbi. The network helps show where Arash Nabbi may publish in the future.

Co-authorship network of co-authors of Arash Nabbi

This figure shows the co-authorship network connecting the top 25 collaborators of Arash Nabbi. A scholar is included among the top collaborators of Arash Nabbi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arash Nabbi. Arash Nabbi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Desai, Kavita, Arash Nabbi, Sean D. Reiff, et al.. (2025). PD‐L1 Expression is Mediated by microRNA Processing, Wnt/β‐Catenin Signaling, and Chemotherapy in Wilms Tumor. Pediatric Blood & Cancer. 72(9). e31852–e31852.

Nabbi, Arash, Arnavaz Danesh, Osvaldo Espin‐Garcia, et al.. (2023). Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab. Nature Cancer. 4(4). 502–515. 5 indexed citations

Selle, Barbara, David Jones, Christian Vokuhl, et al.. (2022). The genomic landscape of pediatric renal cell carcinomas. iScience. 25(4). 104167–104167. 5 indexed citations

Jones, David, Ana Banito, Thomas G. P. Grünewald, et al.. (2019). Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours. Nature reviews. Cancer. 19(8). 420–438. 85 indexed citations

Fink, Dieter, Arash Nabbi, Bettina Wagner, et al.. (2019). Loss of Ing3 Expression Results in Growth Retardation and Embryonic Death. Cancers. 12(1). 80–80. 15 indexed citations

Yang, Yang, et al.. (2019). Biological Functions of the ING Proteins. Cancers. 11(11). 1817–1817. 35 indexed citations

McClurg, Urszula L., Joanne Edwards, Arash Nabbi, et al.. (2018). Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12. Oncogene. 37(34). 4679–4691. 36 indexed citations

McClurg, Urszula L., Arash Nabbi, Charles Ricordel, et al.. (2018). Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein. British Journal of Cancer. 118(5). 713–726. 26 indexed citations

Wang, Fudi, Charles Chesnelong, Yang Yang, et al.. (2017). ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways. Oncogene. 37(3). 286–301. 33 indexed citations

10.

Nabbi, Arash, Urszula L. McClurg, Subhash Thalappilly, et al.. (2017). ING3 promotes prostate cancer growth by activating the androgen receptor. BMC Medicine. 15(1). 103–103. 26 indexed citations

11.

Nabbi, Arash, et al.. (2016). ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients. Tumor Biology. 37(7). 9731–9738. 13 indexed citations

12.

Nabbi, Arash, et al.. (2015). ING3 protein expression profiling in normal human tissues suggest its role in cellular growth and self-renewal. European Journal of Cell Biology. 94(5). 214–222. 15 indexed citations

13.

Nabbi, Arash & Karl Riabowol. (2015). Isolation of Nuclei. Cold Spring Harbor Protocols. 2015(8). pdb.top074583–pdb.top074583. 12 indexed citations

14.

Thakur, Satbir, Arash Nabbi, Alexander C. Klimowicz, & Karl Riabowol. (2015). Stromal ING1 expression induces a secretory phenotype and correlates with breast cancer patient survival. Molecular Cancer. 14(1). 164–164. 9 indexed citations

15.

Nabbi, Arash & Karl Riabowol. (2015). Rapid Isolation of Nuclei from Cells In Vitro. Cold Spring Harbor Protocols. 2015(8). pdb.prot083733–pdb.prot083733. 79 indexed citations

16.

Nabbi, Arash & Karl Riabowol. (2015). Isolation of Pure Nuclei Using a Sucrose Method. Cold Spring Harbor Protocols. 2015(8). pdb.prot083741–pdb.prot083741. 12 indexed citations

17.

McClurg, Urszula L., Victoria Harle, Arash Nabbi, et al.. (2015). Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer. Oncotarget. 6(35). 37724–37736. 14 indexed citations

18.

Satpathy, Shankha, Arash Nabbi, & Karl Riabowol. (2013). RegulatING chromatin regulators: post-translational modification of the ING family of epigenetic regulators. Biochemical Journal. 450(3). 433–442. 12 indexed citations

19.

Nabbi, Arash, Shankha Satpathy, & Karl Riabowol. (2013). Demethylating Agents as Epigenetic Anticancer Therapeutics. Current Cancer Therapy Reviews. 9(1). 24–33. 1 indexed citations

20.

Nabbi, Arash, Shankha Satpathy, & Karl Riabowol. (2013). Demethylating Agents as Epigenetic Anticancer Therapeutics. Current Cancer Therapy Reviews. 9(1). 24–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact